>sp|Q864S8|BRCA2_FELCA Breast cancer type 2 susceptibility protein homolog OS=Felis catus GN=BRCA2
MPIGCKERPTFFEIFRTRCNKADLGPISLNWFEELCLEAPPYNSEPTEESGYKISYEPNL
FKTPQRKPCHQLASTPIIFKEQGLIPPIYQQSPLKELGKDITNSKHRSCCTMKSKMDQTN
DVTSPPLNSCLSESPLLRSTHVTPQREKSVVCGSLFHTPKLTKGQTPKRISESLGAEVDP
DMSWSSSLATPPTLSSTVLIVRDEEASAAVFPNDTTAIFKSYFCNHDESLKKNDRFIPSG
PDSENKSQREAKSQGLGKMVGNSCDKVNSCKDPFGNSTLNVLEDGVRERVADVSEEDSFP
LCVPKCKTRNLQKIKTSKTRKNIFNETTDECKEAKKQMKENKHSFVSEMEANASDPLDSN
VTNQKPFGNGSDKISKEVVLSSASESCHLTLSGLNGTHMEKLPLLCISSCDQNNSEKDLI
TTEKECTNFIILEDSLPQISGVPKCTEKILNEEIVVNKIDEGQCLESHEDSILAVKQAVF
ETSLIASPLQGIRKSIFRIRESPEETFSAVFSNNITDPNFKEEHEASESVLEKHSICSQK
EDSLSTSSLDNGSWPATIKHTSVALKNSGLISTLKKKTKKFIYVVNDETSYQGLKTQKDQ
QSGLMNYSAQFEANVLEGPLTFANADSGLLHSSVKKTCLQNDSKEPILSLTNSFGTLLRK
VSNKGSSSPNNKIISQDLDYKEAKIKKEKLQSFISTETNCLSSLQEKHCEDDTKSQRVAD
RKEEILPAVSQPSVPYSEVEDSGIHFQTLKSFSSDPDKSSQLTPHPRDPPSNPVGLSRGR
ESYEVSETLKCKNHEAGFELTKTMENSQEIHVLNEHAKKAKLLSTEKYVTEASPSMKVPF
NQNAHLTIIQKDQKETTLISKITMNPNSEELFPDGDNFVFKITKERNVPVLGSIKELQDS
DLCCVKEPVLENSTMVVYTDMDDKQAAKVSITKGFDSSNIDDLTEKDRNSIKQQLRMTLD
QDSKSDITLDSDMKSNGNNDYMDNWARLSDPILNHNFGNGFRTASNKEIKLSEHNIKKSK
MLFKDIEERYPTNLACIEIVNTPLESQEKLSKPHILDPQSINTVSGCVQSSAYVSDSENR
HTTPPTLSLKRDFDSNHNLTPSQKAEITELSTILEESGSQFEFTQFRKPSHLKQKNPCEM
PEKHLTISNTTPEEQKDGHLRLTINALSISQGDSSKKFEGIIGGKQKLACLSKTSCNKSA
SGHLTGKNEVEFRGFYSARGTKLNVCSEALQKAKKLFSDLENISEETSVEVDRSFSSSKC
NGSVSMFKKENCNNEKKLNEKNNKYRLILQNNIEMTTGIFVAEDTEGYKRNIENKANKYT
DASRNVYNFREADGSDSSKNDTVYIHKEENGLPYIDQHDIDLKLSSQFIKEGNTQIKEGL
SDLTCLEVVKAEETLHVNTSNKEHLTANTMGRITKDFDIFDVSFQTASGKNIRVSRASLN
KVTNLLDQKCTEEELNNFADSLNSELLSGIDINKADISHHGEMEILKKRQMKESDLTGTE
NKSLTLQQRPEYEIKKIKEPTILGFHTASGKRIEIAKESLDKVKNLFDEQEQDKSEMTNF
SHRGTKMSKGREECEGGLRLACKTIEITPASKEEEMQKPLEKNLVSNEIVVVPRLLSDNL
YKQTENLKIPNRASLKVKVHENTGKETAKKPTTCTNQSTYSATENSALSFYTGHGRKISV
SQSSILEVKKWLRGGELDDQPEKTVYNISEYLPKSKVDNSGIEPVVRNVGERENTSVSEI
MFTVREADTDPQSVNEDICVQRLVTNFSCKKENTAIKVTVSDSNNFDSTQKLNSDSNDAV
PVYTTASSERVLVAHETKVAEGFTENCSMAIKQTTKSKPGKIVAGYRKAPDDSEDTICPN
SLDGAECSSPSHKDFAETQSEQTPQLNQSISGFKKRSEIPPHQINLKTSDICKLSTGKRL
QSISYTNACGIFSTASGKCVQVSDAALQKARQVFSKVEDSAKQPFSKVSFKHNEDHSDKF
TREENTMIHTPQNLLSSAFSGFSTASGKQVPVSESALCKVKGILEEFDVMRTECGPQRSP
TSRQDVSKMPPPSCVENKTPKHSVNSKLEKAYNKEFKLSSNSKIENGSSENHSVQVSPYP
SQFKQDKQLIQGNKASLVENIHLLEKEQALPKNIKWKLETEAFPNLPLKTDTAIHSTDSK
DPENYFETETVEIAKAFMEDGELTDADLLSHARHFLPTCQHSEETLVSNSRRGKRRGVLV
SVGEPPIKRNLLNEFDRIIKNQEKSLKASKSTPDGIIKDRSLFMHHISLEPVTCGPFSTT
KKRQEIQNPNFTAPGQKFLSKSHFYEHLALEKSSSNVSISGQPFCTVPATRSEKRGHSIT
PSKPVKVFVPPFKTKSRFLQDEQHISKNTHVEENKQKPNNIDEHSSGDSKNNINNSEIHQ
LNKNNSSQAATMVFTKCEKEPLDLIASLQNARDIQDMRIREKRKQHIFPQPGSLFLAKTS
TVPRISLRVAVEGRVPSACSHKQLYMYGVSKHCVKINSKNAESFQFHTQDYFGKEVQWAK
EGIQLADGGWLIPSNDGKAGKEEFYRALCDTPGVDPNLISRIWVYNHYRWIIWKLAAMEF
AFPKEFANRCLSPERVLLQLKYRYDMEIDRSKRSAIKKIMERDDTAAKTLVLCISETISS
STDLSETSGSKTSGVGTKNVGIVELTDGWYAIKAQLDPPLLALVKKGRLTVGHKIIIHGA
ELAGSPDACTPLEAPESLILKISANSTRPACWYAKLGFFPDPRPFPLPLSSLFSDGGNVG
CVDVVIQRTYPIQWMEKTPSGLCIFRNEREEEREATKYAEAQQKKLEVLFNKIQAEFEKH
DENITKRCVPLRALTRQQVCALQDGAELYEAVKNAPDPASLEAYFSEEQIRALNNHRQML
NDKKQAQIQLEFRKAMESAEQGEQMLPRDVTTVWKMRIISYGKKEKDSVTLSIWRPSSDL
YSLLTEGKRYRIYHLATSQSKSKSERAHIQLTATKKTQYQQLPASDELLFQVYQPREPLY
FNKLLDPDFQPPCSEVDLIGFVVSVVKKIGFAPLVYLSDECHNLLAIKVWTDLNEDIVKP
HTLIAASNLQWRPESKSGIPTLFAGDFSRFSASPKEGHFQETFHKMKNTIENVETFCNDA
ENKLVHILNANSPKVSTPMKDYASEPHTIQTVLGLGNKLSMSSPNSEMNYQSPLSLCKPK
AKSVPTPGSAQMTSKSCYKGERELDDPKTCKKRKALDFLSRLPLPPPVSPICTFVSPAAQ
KAFQPPRSCGTKYETPIKKRELNSPQMTPLKFNDTSLVESDSIADEELALINTQALLSGL
AGEDQLMSLNDSPRTAPTSSKDYVRPKSYPTAPGIRDCENPQASTEGGEPDVQDTDTVKR
SSMRLQRRQQQT